Fruit flies steal bacterial defense to survive parasitic wasps

In the continual arms race between parasites and their hosts, innovation was thought to be the key to a successful attack or defense that one-ups the competition.

Bluebird in fundraising mode: A $150M public offering and a deal to get cash early from gene therapy sales

Facing a financial void it had hoped to be filled by a priority review voucher, bluebird bio is tapping two different sources to bring in

December 20, 2023

Cardiac psychologists are pushing to protect heart patients’ often-overlooked mental health

Margery Quackenbush was attending a board meeting of the nonprofit where she served as executive director when she felt a sharp, stabbing pain in her

January 3, 2024

Climb Bio enters deal with Mabworks for CLYM116 development

Climb Bio is currently conducting IND-enabling studies for the therapy. Credit: PeopleImages.com – Yuri A / Shutterstock. Climb Bio has entered an exclusive licence agreement

January 10, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.